V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310004232 | 310001822 | 1.59 | 104.8 | Palliative (P) | 2017-07-13 | 2017-07-21 | ECX | N | N | 310019485 | ECX |
| 310004233 | 310006785 | 1.76 | 78.4 | Curative (C) | 2016-06-24 | 2016-07-04 | Capecitabine + Cisplatin | N | Y | 310019486 | DACARBAZINE |
| 310004234 | 310006785 | 1.55 | 139 | Palliative (P) | 2015-07-21 | 2015-08-05 | EOX | N | N | 310019486 | RITUXIMAB |
| 310004235 | 310001823 | 1.77 | 75 | null | 2016-01-18 | 2016-01-25 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 310019490 | ICON TRIAL |
| 310004236 | 310001824 | 1.74 | 75 | Neo-adjuvant (N) | 2017-02-26 | 2017-03-13 | IMATINIB | N | N | 310019491 | LIPOSOMAL DOXORUBICIN |
| 310004237 | 310001825 | 1.69 | 0 | Palliative (P) | 2017-04-10 | 2017-04-14 | Capecitabine + Cisplatin | N | N | 310019492 | BEXAROTENE |
| 310004238 | 310001826 | 0 | 1.8 | Disease modification (D) | 2014-03-09 | 2017-12-22 | Dacarbazine | N | N | 310019493 | CISPLATIN + FLUOROURACIL |
| 310004239 | 310001826 | null | null | Palliative (P) | 2017-10-08 | 2017-10-13 | Capecitabine + Cisplatin | N | N | 310019493 | OXALIPLATIN + MDG |
| 310004240 | 310001827 | 1.67 | null | Palliative (P) | 2013-06-30 | 2013-06-30 | Liposomal Doxorubicin 40mg/m2 | null | null | 310019495 | EOX |
| 310004241 | 310001828 | 1.76 | 47 | Neo-adjuvant (N) | 2013-05-02 | 2013-05-09 | Vemurafenib | 02 | N | 310019499 | BCG |
| 310004242 | 310001829 | 1.82 | 69.6 | null | null | 2017-12-13 | GEMCITABINE | Y | N | 310019500 | GEMCITABINE |
| 310004243 | 310001830 | 1.62 | 58.1 | Palliative (P) | 2016-02-15 | 2016-02-23 | Vemurafenib | 2 | N | 310019505 | ICON TRIAL |
| 310004244 | 310001831 | 0 | 70.1 | Palliative (P) | 2016-08-11 | 2017-04-01 | BCG Intravesical | N | N | 310019507 | EOX |
| 310004245 | 310001832 | 1.64 | 65.6 | Palliative (P) | 2016-08-19 | 2016-08-19 | Hydroxycarbamide | 02 | N | 310019511 | CISPLATIN + FLUOROURACIL |
| 310004246 | 310001833 | 1.71 | 74.6 | Palliative (P) | 2014-01-16 | 2014-01-18 | Vemurafenib | 2 | N | 310019514 | BEXAROTENE |
| 310004247 | 310006787 | 1.69 | null | Palliative (P) | null | 2014-11-04 | Capecitabine + Oxaliplatin 14day | 02 | N | 310019515 | OXALIPLATIN + MDG |
| 310004248 | 310001834 | 1.77 | 82 | Curative (C) | 2013-12-13 | 2013-12-15 | CISPLATIN + CYCLOPHOSPHAMIDE + ETOPOSIDE + VINCRISTINE | N | N | 310019517 | NOT MATCHED |
| 310004249 | 310001835 | 0 | 44.8 | Palliative (P) | 2013-02-16 | 2013-02-16 | GEM-P | null | Y | 310019518 | PACLITAXEL |
| 310004252 | 310001836 | 0 | 81.5 | Not known (9) | 2017-02-18 | 2017-02-22 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 310019524 | CISPLATIN + FLUOROURACIL |
| 310004253 | 310001837 | null | 0 | Palliative (P) | 2015-11-16 | 2015-11-22 | EOX | 2 | N | 310019525 | OXALIPLATIN + MDG |
| 310004254 | 310001837 | null | 72 | Neo-adjuvant (N) | 2014-03-13 | 2014-03-24 | Hydroxycarbamide | N | N | 310019525 | CISPLATIN + ETOPOSIDE |
| 310004255 | 310001838 | 1.86 | 61.1 | Palliative (P) | 2014-11-05 | 2014-11-09 | Dacarbazine | N | N | 310019530 | DACARBAZINE |
| 310004256 | 310001839 | 1.61 | 58.25 | null | null | 2017-09-26 | null | 2 | N | 310019531 | NOT MATCHED |
| 310004257 | 310001839 | 1.53 | 66.5 | Palliative (P) | 2016-07-23 | 2016-07-31 | Mitomycin Intravesical | Y | N | 310019531 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 310004258 | 310009157 | 1.68 | 65.6 | 4 | 2015-04-05 | 2015-04-15 | Capecitabine | N | N | 310019535 | EOX |
| 310004259 | 310001840 | 1.63 | 52.8 | Palliative (P) | null | 2017-07-20 | Mitomycin Intravesical | 02 | N | 310019536 | CAPECITABINE + CISPLATIN |
| 310004260 | 310001841 | 1.69 | 74 | Disease modification (D) | 2018-04-10 | 2018-04-10 | Dacarbazine | 2 | N | 310019538 | IMATINIB |
| 310004261 | 310001842 | null | 113.8 | Palliative (P) | 2016-11-04 | 2016-11-06 | ECX | N | N | 310019539 | ECX |
| 310004262 | 310001843 | 1.46 | 54 | Palliative (P) | 2014-03-07 | 2014-03-07 | Gemcitabine weekly | N | N | 310019542 | GEMCITABINE |
| 310004263 | 310001844 | 1.63 | 86.35 | Palliative (P) | 2015-11-29 | 2015-11-29 | CAPECITABINE + OXALIPLATIN | N | N | 310019543 | CAPECITABINE + CISPLATIN |
| 310004264 | 310001844 | 1.59 | 63.2 | Palliative (P) | 2017-11-14 | 2017-11-19 | ECX | 02 | N | 310019543 | ECX |
| 310004265 | 310001845 | null | 58.25 | Curative (C) | 2017-08-03 | 2017-08-04 | CHOEP - 21 days | 02 | N | 310019545 | CHOEP |
| 310004266 | 310001846 | null | 72 | Palliative (P) | 2016-08-23 | 2016-09-16 | Imatinib 400mg | 02 | N | 310019546 | GEMCITABINE + PACLITAXEL |
| 310004267 | 310001847 | null | 49.8 | Palliative (P) | 2017-02-23 | 2017-03-07 | IPILIMUMAB + NIVOLUMAB | 01 | null | 310019547 | IPILIMUMAB + NIVOLUMAB |
| 310004268 | 310001847 | null | null | Palliative (P) | 2016-08-01 | 2016-08-14 | Oxaliplatin + Modified de Gramont | 02 | N | 310019547 | HYDROXYCARBAMIDE |
| 310004269 | 310009158 | 1.73 | 79.2 | null | null | 2014-06-20 | Rituximab | N | N | 310019553 | OXALIPLATIN + MDG |
| 310004270 | 310001848 | 1.58 | 72.15 | Disease modification (D) | 2015-04-11 | 2015-04-11 | CHOEP | 2 | N | 310019554 | CISPLATIN + ETOPOSIDE |
| 310004271 | 310006793 | 0 | 63.8 | Palliative (P) | 2015-11-01 | 2015-11-22 | IPILIMUMAB + NIVOLUMAB | N | N | 310019558 | IPILIMUMAB + NIVOLUMAB |
| 310004272 | 310006793 | null | null | Palliative (P) | 2017-12-11 | 2017-12-19 | IPILIMUMAB + NIVOLUMAB | 2 | N | 310019558 | IPILIMUMAB + NIVOLUMAB |
| 310004273 | 310006793 | null | null | Palliative (P) | 2014-11-05 | 2014-11-08 | Imatinib 400mg | null | null | 310019558 | CAPECITABINE + CISPLATIN |
| 310004274 | 310006793 | null | 104 | Palliative (P) | 2013-02-10 | 2017-12-11 | ECX | N | N | 310019558 | ECX |
| 310004275 | 310006793 | 1.62 | 68.7 | Curative (C) | 2017-09-09 | 2017-09-13 | null | N | N | 310019558 | NOT MATCHED |
| 310004278 | 310009160 | 1.73 | 71 | Not known (9) | 2017-06-17 | 2017-06-27 | CYCLOPHOSPHAMIDE + DOXORUBICIN + EPIRUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE | 02 | N | 310019567 | IMATINIB |
| 310004279 | 310001850 | 1.54 | 60.6 | Curative (C) | null | 2016-11-07 | Mitomycin Intravesical | N | N | 310019569 | VEMURAFENIB |
| 310004280 | 310001851 | 1.69 | null | Palliative (P) | 2017-10-25 | 2018-01-07 | ECX | N | null | 310019570 | ECX |
| 310004283 | 310001853 | 1.71 | 82.1 | Disease modification (D) | 2015-06-03 | 2015-06-03 | Liposomal Doxorubicin (Caelyx) | null | N | 310019575 | EOX |
| 310004284 | 310001854 | 1.19 | 77.4 | Palliative (P) | 2016-11-05 | 2016-11-10 | IPILIMUMAB + NIVOLUMAB | N | null | 310019578 | IPILIMUMAB + NIVOLUMAB |
| 310004285 | 310001855 | null | 58.8 | Disease modification (D) | 2017-08-12 | 2017-08-15 | Dacarbazine | Y | N | 310019579 | VEMURAFENIB |
| 310004286 | 310001856 | 1.62 | 60.2 | Neo-adjuvant (N) | 2017-06-02 | 2017-06-17 | Hydroxycarbamide | 02 | N | 310019580 | DACARBAZINE |
| 310004287 | 310001857 | 1.67 | 83 | Palliative (P) | 2013-12-29 | 2013-12-31 | Vemurafenib | null | null | 310019583 | HYDROXYCARBAMIDE |